| Name | Golden Pharmacy |
|---|---|
| Organization Name | Golden Pharmacy,inc |
| Location | 17324 Main St N, Blountstown, Florida 32424 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (850) 674-4557 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
For her thesis entitled Conjugated Linoleic Acid and Resveratrol: the effect of these functional ingredients on the metabolism of triglycerides and adiposity, Nutrition and Obesity research team member at the University of the Basque Country, Ms Arrate Lasa, studied the fat-reducing effect of CLA and resveratrol.
Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it has entered into an agreement to sell $30 million of shares of its Series 2 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to a single institutional investor. Each share of Series 2 Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 628 shares of common stock at a conversion price of $1.59125 per share of common stock for a total of approximately 18,853,103 common shares.
To help hospitals and health systems prepare for the impending payment changes associated with health care reform initiatives and a changing incentive structure, Sg2, a future-focused health care intelligence company, has released an innovative new tool - the Sg2 Reform Readiness Analysis.
So-called type-3 secretion systems of pathogenic bacteria may be a suitable point of attack for future antibiotics. This is shown by Professor Maria Fällman and her associates at Umeå University in Sweden in the Proceeding of the National Academy of Sciences, PNAS, in the US.
› Verified 2 days ago
| NPI Number | 1174624365 |
| Organization Name | GOLDEN PHARMACY,INC |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 17324 Main St N, Blountstown, FL 32424 |
| Phone Number | 850-674-4557 |
News Archive
For her thesis entitled Conjugated Linoleic Acid and Resveratrol: the effect of these functional ingredients on the metabolism of triglycerides and adiposity, Nutrition and Obesity research team member at the University of the Basque Country, Ms Arrate Lasa, studied the fat-reducing effect of CLA and resveratrol.
Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it has entered into an agreement to sell $30 million of shares of its Series 2 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to a single institutional investor. Each share of Series 2 Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 628 shares of common stock at a conversion price of $1.59125 per share of common stock for a total of approximately 18,853,103 common shares.
To help hospitals and health systems prepare for the impending payment changes associated with health care reform initiatives and a changing incentive structure, Sg2, a future-focused health care intelligence company, has released an innovative new tool - the Sg2 Reform Readiness Analysis.
So-called type-3 secretion systems of pathogenic bacteria may be a suitable point of attack for future antibiotics. This is shown by Professor Maria Fällman and her associates at Umeå University in Sweden in the Proceeding of the National Academy of Sciences, PNAS, in the US.
› Verified 2 days ago
News Archive
For her thesis entitled Conjugated Linoleic Acid and Resveratrol: the effect of these functional ingredients on the metabolism of triglycerides and adiposity, Nutrition and Obesity research team member at the University of the Basque Country, Ms Arrate Lasa, studied the fat-reducing effect of CLA and resveratrol.
Cell Therapeutics, Inc. (Nasdaq and MTA: CTIC) (the "Company") today announced that it has entered into an agreement to sell $30 million of shares of its Series 2 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to a single institutional investor. Each share of Series 2 Preferred Stock is convertible at the option of the holder, at any time during its existence, into approximately 628 shares of common stock at a conversion price of $1.59125 per share of common stock for a total of approximately 18,853,103 common shares.
To help hospitals and health systems prepare for the impending payment changes associated with health care reform initiatives and a changing incentive structure, Sg2, a future-focused health care intelligence company, has released an innovative new tool - the Sg2 Reform Readiness Analysis.
So-called type-3 secretion systems of pathogenic bacteria may be a suitable point of attack for future antibiotics. This is shown by Professor Maria Fällman and her associates at Umeå University in Sweden in the Proceeding of the National Academy of Sciences, PNAS, in the US.
› Verified 2 days ago
Golden Pharmacy Type: Durable Medical Equipment & Medical Supplies Supplier Location: 17324 Main St N, Blountstown, Florida 32424 Phone: (850) 674-4557 | |
Blountstown Drugs Inc Type: Medicare Supplier Location: 20370 Central Ave W, Blountstown, Florida 32424 Phone: (850) 674-2222 |